Pliant Therapeutics Inc (PLRX) financials · $77.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Pliant Therapeutics Inc (PLRX) $77.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$156.4M | -$228.4M |
| Net Income | -$149.3M | -$210.3M |
| EPS (Diluted) | -$2.43 | -$3.47 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $225.2M | $396.9M |
| Current Assets | $196.4M | $362.3M |
| Cash & Equivalents | $45.4M | $71.2M |
| PP&E | $2.94M | $5.53M |
| Total Liabilities | $44.0M | $92.9M |
| Current Liabilities | $16.4M | $33.2M |
| Long-term Debt | N/A | $30.2M |
| Total Debt | N/A | $30.2M† |
| Shareholders' Equity | $181.2M | $304.1M |
| Retained Earnings | -$859.4M | -$710.1M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$128.3M | -$155.5M |
| CapEx | $374.0K | $3.85M |
| Investing Cash Flow | $134.3M | $140.3M |
| Financing Cash Flow | -$31.7M | $23.1M |
| Net Change in Cash | -$25.7M | $7.95M |
| Free Cash Flow | -$128.7M | -$159.4M |
FAQ
What is PLRX P/E and revenue?
Pliant Therapeutics Inc (PLRX) $77.3M cap.
What is PLRX revenue?
PLRX income-statement cache has no revenue figure yet.
Is PLRX profitable?
Pliant Therapeutics Inc last cached net income is -$149.3M (FY2025).
What are PLRX total assets?
Pliant Therapeutics Inc last cached total assets are $225.2M (FY2025).
What is PLRX free cash flow?
Pliant Therapeutics Inc last cached free cash flow is -$128.7M (FY2025).
Not investment advice. Cached statements, not a live tape.